Almost 1 in 2 people living with incontinence experience skin irritation, Ontex research shows
For World Skin Health Day, Ontex highlights the critical need for skin protection in personal hygiene and introduces its new skin-focused Sensitive range.
Ontex convenes special general shareholders’ meeting
Ontex NV Group convenes a special general shareholders’ meeting on Wednesday, July 29, 2026
Transparency Declaration Notification
On June 1, 2026, the voting rights and number of equivalent financial instruments held by the Goldman Sachs Group, Inc. crossed downward the threshold of 3%.
Ontex 2026 shareholders’ meeting: all resolutions approved
Ontex Group NV held its 2026 shareholder's meeting. All resolutions were approved.
Transparency Declaration Notification
On April 22, 2026, the number of equivalent financial instruments held by the Goldman Sachs Group, Inc. crossed the threshold of 3% for equivalent financial instruments.
Transparency Declaration Notification
On April 15, 2026, the number of equivalent financial instruments held by the Goldman Sachs Group, Inc. crossed the threshold of 3% of issued shares downward.
Transparency Declaration Notification
On March 23, 2026, the number of voting rights held by Mr. Joannes G.H.M. Niessen and Mont Cervin SARL crossed the threshold of 3% of issued shares downward
Ontex publishes its 2025 annual report: ‘Building foundations for the future’
Ontex Group NV today publishes its 2025 annual report. The annual report covers Ontex’s financial, environmental, social and governance data for the year 2025, as well as its leadership and strategy.
Transparency Declaration Notification
On March 4, 2026, the Company received a transparency declaration confirming that, on February 27, 2025, the Goldman Sachs Group, Inc., detained 6,388 Ontex voting rights and 2,625,088 equivalent financial instruments or 2,631,476 in total, representing respectively 0.01%, 3.19% and 3.20% of Ontex’s issued shares. The holding of equivalent financial instruments thereby crossed upward the threshold of 3% for equivalent financial instruments.
